Our mission is to support our patients with mental or neurological disorders from the initial diagnostic to the end of the intervention, offering them state of the art technology to evaluate and treat ...
Stockhead on MSN
Entropy’s psilocybin therapy shows rapid and sustained reduction of binge eating in 100pc of patients
Clinical-stage biotech Entropy Neurodynamics has received positive Phase 2a results for its psilocybin-based therapy in ...
Entropy Neurodynamics Limited, a clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback